However, a recent study showed that celecoxib failed to prevent the generation of schwannomas in a genetically engineered mouse model of NF2 inactivation, although COX-2 expression was increased in tumors that developed in these mice [115]. This evidence concerns the gene PTGS2 and schwannoma.